A detailed analysis of the Global Magnetic Resonance Angiography (MRA) Market 2023 is provided, including global, regional, and country-level market sizes, segmentation market growth, market share, competitive landscape, sales analysis, impact of domestic and global Magnetic Resonance Angiography (MRA) Market players, value chain optimization, trade regulations, recent developments, strategic market growth analyses, product launches, expanding the area market, and technological advances.
The global Magnetic Resonance Angiography (MRA) market size was USD 2.89 Billion in 2022 and is expected to reach USD 4.48 Billion in 2032, and register a revenue CAGR of 5 % during the forecast period. Magnetic Resonance Angiography (MRA) is a non-invasive diagnostic imaging technology that creates fine-grained images of the body's blood arteries using Magnetic Resonance Imaging (MRI). The prevalence of cardiovascular disorders is increasing, the population is aging, and imaging technology developments are driving market revenue growth.
In the pharmaceutical and healthcare sectors, there is rapid change. As cell and gene therapies become increasingly available, patients are finding appropriate treatments for previously incurable diseases. Machine learning and artificial intelligence (AI) technologies are making it possible for more inventive, faster, and cheaper therapy development to take place. By utilizing data-driven projects, manufacturing, the supply chain, and the entire healthcare ecosystem can benefit. It is clear that consumer attitudes and behaviors are shifting, ranging from a greater use of technology and data sharing to a willingness to use tools to make prescriptions and treatment decisions. Pharma and healthcare markets are expected to grow in the next few years as a result of such factors.
Key Players covered in this report are
GE Healthcare
Siemens Healthineers
Philips Healthcare
Bayer AG
Toshiba Corporation
Bracco Imaging S.p.A.
Fujifilm Holdings Corporation
Koninklijke Philips N.V.
Shimadzu Corporation
Canon Medical Systems Corporation
Based on Technology Type market is segmented into:
In 2021, GE Healthcare and Vanderbilt University Medical Center announced a partnership to develop Artificial Intelligence (AI) algorithms for improved diagnosis and treatment of cancer, heart disease, and other medical conditions. The partnership aims to combine GE's advanced imaging technology and Vanderbilt's expertise in AI and Machine Learning to develop innovative diagnostic tools.
In 2020, Siemens Healthineers announced the acquisition of Varian Medical Systems, a leading manufacturer of radiation therapy equipment, for USD 16.4 billion. The acquisition aims to expand Siemens Healthineers' oncology portfolio and strengthen its position in the global healthcare market.
In 2020, Philips Healthcare acquired Intact Vascular, a Medical Device company that develops minimally invasive treatments for peripheral artery disease. The acquisition aims to expand Philips' portfolio of image-guided therapies and strengthen its position in the vascular healthcare market.
In 2019, Bayer AG acquired BlueRock Therapeutics, a biotech company that specializes in developing regenerative therapies for various diseases. The acquisition aims to strengthen Bayer's position in the field of Cell Therapy and Regenerative Medicine.
In 2020, GE Healthcare launched the SIGNA Premier MRI system, which features advanced imaging capabilities and improved patient comfort. The system uses AI algorithms to enhance image quality and reduce scan times, making it suitable for a wide range of clinical applications.
In 2019, Siemens Healthineers launched the MAGNETOM Lumina MRI system, which features advanced imaging capabilities and improved patient comfort. The system uses AI algorithms to enhance image quality and reduce scan times, making it suitable for a wide range of clinical applications.
In 2020, Philips Healthcare launched the Azurion image-guided therapy platform, which features advanced imaging capabilities and real-time guidance for interventional procedures. The platform uses AI algorithms to enhance image quality and improve patient outcomes.
In 2020, Bayer AG launched the Gadavist 1.0 M solution, a contrast agent used in MRA procedures. The solution provides high-quality images of blood vessels and improves the accuracy of diagnoses.
We can also provide the customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.